The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia

被引:30
|
作者
Moayyedi, P [1 ]
Zilles, A [1 ]
Clough, M [1 ]
Hemingbrough, E [1 ]
Chalmers, DM [1 ]
Axon, ATR [1 ]
机构
[1] Gen Infirm, Ctr Digest Dis, Leeds LS1 3EX, W Yorkshire, England
关键词
C-13-UBT; dyspepsia; Helicobacter pylori; open access endoscopy;
D O I
10.1097/00042737-199911000-00010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aims (1) To investigate the effects of a Helicobacter pylori screening and treatment strategy on open access endoscopy referral rates in dyspeptic patients aged < 40 years. (2) To determine the effectiveness of an H. pylori screening and treatment strategy, compared with endoscopy, in reducing dyspeptic symptoms, and in the utilization of dyspepsia related health care in general practice. Subjects Subjects were dyspeptic patients aged < 40 years, who were not taking NSAIDs and were without sinister symptoms. Patients were referred by their general practitioners. Methods The proportion of endoscopies carried out in patients aged < 40 years during the 5 years before the introduction of a screening and treatment strategy was compared with the proportion 2 years afterwards, as determined in a retrospective audit Dyspepsia scores were obtained from unselected endoscopy patients and those who received a C-13-urea breath test (C-13-UBT) at their initial visit and 6 months later. The number of visits made by patients with dyspepsia to their GPs, as well as the number of prescriptions given for antisecretory drugs, during the 6 months before attending for investigation were compared, in the same patient groups, with the same variables during the 6 months after the investigation. Results There was a 37% reduction in open access endoscopies performed in patients aged < 40 years (95% CI, 34-40%) following the introduction of the 13C-UBT service. Six months after attending the C-13-UBT service there was a significant fall in dyspepsia score (15.5 +/- 7.4 to 7.2 +/- 7.0, P < 0.0001), general practice dyspepsia consultations (2.0 +/- 1.3 to 1.0 +/- 1.7, P < 0.0001), H-2 receptor antagonist prescription (14.2 +/- 32.6 tablets to 6.7 +/- 25.6 tablets, P = 0.006) but not proton pump inhibitor prescription (6.9 +/- 21.9 tablets to 7.2 +/- 27.6 tablets, P = 0.90). These changes were not significantly different from those found in the open access endoscopy control patients. Conclusions An H. pylori screening and treatment strategy reduces the endoscopy workload in young dyspeptic patients. This strategy appears to be as effective as endoscopy in reducing dyspepsia symptoms, dyspepsia consultation rates and the prescribing of anti-secretory drugs. Eur J Gastroenterol Hepatol 11:1245-1250 (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:1245 / 1250
页数:6
相关论文
共 50 条
  • [31] Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia - Studies assumptions are removed from clinical practice
    Trimble, I
    Derrett, C
    [J]. BRITISH MEDICAL JOURNAL, 1996, 313 (7057): : 622 - 623
  • [32] Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia - Analysis is easier with spreadsheets than decision trees
    Hall, GH
    Daneshmend, TK
    Round, AP
    Ayres, R
    [J]. BRITISH MEDICAL JOURNAL, 1996, 313 (7057): : 622 - 622
  • [33] Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia - Costs will probably vary according to local data
    Pugh, S
    [J]. BRITISH MEDICAL JOURNAL, 1996, 313 (7057): : 622 - 622
  • [34] THE CLINICAL EFFECTIVENESS OF PROBIOTICS AND AUTOPROBIOTICS IN TREATMENT OF HELICOBACTER PYLORI-ASSOCIATED DYSPEPSIA
    Ermolenko, E. I.
    Molostova, A. S.
    Baryshnikova, N. V.
    Svarval, A. V.
    Gladyshev, N. S.
    Kashchenko, V. A.
    Suvorov, A. N.
    [J]. INFEKTSIYA I IMMUNITET, 2022, 12 (04): : 726 - 734
  • [35] Primary care dyspepsia management in the Helicobacter pylori (HP) era.
    Greenaway, JR
    Cann, PA
    [J]. GUT, 1997, 40 : F230 - F230
  • [36] Helicobacter pylori infection and dyspepsia in pregnancy
    McKenna, D
    Watson, P
    Dornan, J
    [J]. OBSTETRICS AND GYNECOLOGY, 2003, 102 (04): : 845 - 849
  • [37] Non ulcer dyspepsia and Helicobacter pylori
    Debongnie, JC
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 1998, 61 (04): : 476 - 478
  • [38] The role of Helicobacter pylori in nonulcer dyspepsia
    Zaramboukas, T
    Zaramboukas, T
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 35 (05): : 706 - 707
  • [39] Helicobacter pylori infection and dyspepsia in pregnancy
    Cevrioglu, AS
    [J]. OBSTETRICS AND GYNECOLOGY, 2004, 103 (05): : 1005 - 1005
  • [40] HELICOBACTER-PYLORI AND NONULCER DYSPEPSIA
    HOLCOME, C
    [J]. TROPICAL DOCTOR, 1992, 22 (04) : 174 - 175